| scholarly article | Q13442814 |
| P50 | author | Francesc Moreso | Q43129411 |
| Inés Rama | Q54659109 | ||
| P2093 | author name string | Daniel Serón | |
| Joan Torras | |||
| Josep M Cruzado | |||
| Josep M Grinyó | |||
| Oriol Bestard | |||
| Montse Gomà | |||
| Salvador Gil-Vernet | |||
| P2860 | cites work | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor | Q28595009 | ||
| International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | Q34354852 | ||
| Identification of regulatory T cells in tolerated allografts | Q34524237 | ||
| Strategies to improve long-term outcomes after renal transplantation | Q34539775 | ||
| Messenger RNA for FOXP3 in the urine of renal-allograft recipients | Q34563002 | ||
| Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes | Q34585878 | ||
| Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts | Q35928910 | ||
| Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. | Q36189566 | ||
| Ultra-localization of Foxp3+ T cells within renal allografts shows infiltration of tubules mimicking rejection. | Q36202867 | ||
| Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells | Q37317866 | ||
| Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center | Q38514231 | ||
| Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function | Q39765166 | ||
| A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells | Q40297048 | ||
| The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy | Q44378940 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation | Q44869703 | ||
| Regulatory CD25+ T cells in human kidney transplant recipients | Q47895876 | ||
| Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. | Q54622675 | ||
| Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs | Q57702564 | ||
| Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss | Q62619830 | ||
| PROTOCOL RENAL ALLOGRAFT BIOPSIES AND THE DESIGN OF CLINICAL TRIALS AIMED TO PREVENT OR TREAT CHRONIC ALLOGRAFT NEPHROPATHY1 | Q62619846 | ||
| Disparity between solid-organ supply and demand | Q73806363 | ||
| Beneficial effects of treatment of early subclinical rejection: a randomized study | Q77530459 | ||
| The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies | Q78124975 | ||
| Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection | Q79740578 | ||
| The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection | Q79767141 | ||
| Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 | ||
| Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants | Q79967854 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 2020-2026 | |
| P577 | publication date | 2008-05-21 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts | |
| P478 | volume | 19 |
| Q38791064 | A model of acute renal allograft rejection in outbred Yorkshire piglets |
| Q50632486 | Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: The Promise and the Stumbling Blocks. |
| Q38835393 | Alloimmunity and Tolerance in Corneal Transplantation |
| Q38398029 | Analysis of FOXP3 gene and protein expressions in renal allograft biopsies and their association with graft outcomes. |
| Q42185296 | Are we ready for the use of foxp3(+) regulatory T cells for immunodiagnosis and immunotherapy in kidney transplantation? |
| Q40955651 | Association of Foxp3 Polymorphism With Allograft Outcome in Kidney Transplantation |
| Q45132751 | Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection. |
| Q43061612 | Biomarkers in renal transplantation. |
| Q48785899 | Blood biomarkers of kidney transplant rejection, an endless search? |
| Q39957158 | Can protocol biopsy better inform our choices in renal transplantation? |
| Q39279238 | Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells |
| Q37798699 | Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation |
| Q51734645 | Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay. |
| Q37974480 | Clinical role of the renal transplant biopsy |
| Q83736775 | Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection |
| Q51021017 | Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. |
| Q38510977 | Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection |
| Q83797588 | Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients |
| Q85203273 | Eicosapentaenoic Acid Disrupts the Balance Between Tregs and IL-17+ T Cells Through PPARγ Nuclear Receptor Activation and Protects Cardiac Allografts |
| Q47204087 | Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin |
| Q59240791 | Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts |
| Q48089163 | FOXP3+ T cells are present in kidney biopsy samples in children with tubulointerstitial nephritis and uveitis syndrome. |
| Q37937127 | FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance |
| Q39066197 | FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance |
| Q43281190 | FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis |
| Q40266578 | HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion |
| Q82540613 | High Levels of IDO-Expressing CD16+ Peripheral Cells, and Tregs in Graft Biopsies From Kidney Transplant Recipients Under Belatacept Treatment |
| Q40831146 | High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipients |
| Q37798703 | How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belatacept |
| Q89965503 | Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection |
| Q33827314 | Immune reconstitution following rabbit antithymocyte globulin. |
| Q37773304 | Immunotherapy with regulatory T cells in transplantation. |
| Q37529334 | Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection |
| Q94528590 | In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification |
| Q37109198 | Induced regulatory T cells in allograft tolerance via transient mixed chimerism |
| Q37996078 | Induction therapy in renal transplant recipients: how convincing is the current evidence? |
| Q39035802 | Kidney Fibrosis: Origins and Interventions |
| Q33767453 | Kidney transplantation in the elderly |
| Q42042533 | Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation |
| Q46260422 | Low utility of serum 25-hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
| Q64907480 | Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia. |
| Q38089948 | Molecular monitoring for rejection and graft outcome in kidney transplantation |
| Q33562254 | Molecular phenotypes of acute rejection predict kidney graft prognosis |
| Q37892320 | Molecular phenotypes of kidney graft rejection |
| Q38654764 | Pathological conditions re-shape physiological Tregs into pathological Tregs |
| Q36183387 | Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function |
| Q38614123 | Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects |
| Q38662974 | Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. |
| Q39957970 | Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts. |
| Q38069412 | Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies |
| Q37370851 | Prolonged acceptance of skin grafts induced by B cells places regulatory T cells on the histopathology scene |
| Q49483423 | RNA expression profiling of nonhuman primate renal allograft rejection identifies tolerance. |
| Q26800184 | Regulatory T Cells in Kidney Transplantation: New Directions? |
| Q37855647 | Regulatory T cells in lung transplantation--an emerging concept |
| Q64254119 | Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival |
| Q36638732 | Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates |
| Q36314949 | T Lymphocyte-Specific Activation of Nrf2 Protects from AKI. |
| Q35803977 | T-cell activation and transplantation tolerance |
| Q38217596 | Taming inflammation by targeting cytokine signaling: new perspectives in the induction of transplantation tolerance |
| Q37854490 | Tolerance in clinical transplantation: progress, challenge or just a dream? |
| Q37573199 | Transcriptional Perturbations in Graft Rejection |
| Q61805676 | Transient increase of activated regulatory T cells early after kidney transplantation |
| Q28066728 | Tregs and kidney: From diabetic nephropathy to renal transplantation |
| Q89878782 | Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology |
| Q35286904 | α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection |
Search more.